Company

Experience, initiative and a shared direction.

JeCo GmbH was founded by Teresa Kimmel-Seemann in June 2020. Its name combines the first names of her two daughters, giving the company a family connection from the outset.

Robert Seemann initially supported its development as Teresa’s partner, contributing his technical and digital expertise to building the business.

Since their marriage in October 2022, they have continued this shared path as a married couple. Today, JeCo has a strong family character in which professional expertise, personal responsibility and dependable mutual support are closely connected.

Industry experience became an independent company.

Teresa Kimmel-Seemann has extensive experience across various areas of the pharmaceutical and healthcare sectors. Her professional background in food technology and pharmaceutical distribution has shaped her understanding of quality, procurement and customer requirements.

Robert Seemann added technical and scientific thinking, IT expertise and automated data processes. The result was an operating model that combines commercial, pharmaceutical and technical perspectives.

Our path is your destination — direct, dependable and focused on what matters.

People at JeCo

Contacts

TKS

Teresa Kimmel-Seemann

Founder, managing shareholder & quality management auditor

Responsible for strategic development, pharmaceutical partnerships, quality management and commercial management. Her experience as a quality management auditor supports the structured assessment and continual improvement of quality-related processes.

RS

Robert Seemann

Systems Tinkerer, web development & operational processes

Responsible for digital processes, data structures, web development and technical implementation. As a Systems Tinkerer, he combines his mechanical engineering background with broad technical expertise and the systematic development of operational workflows.

Milestones

Development

2020

Foundation

JeCo GmbH begins as a specialised distribution partner for the healthcare market.

2022

Joint development

Internal structures expand, combining market expertise with technical automation.

2025

Wholesale authorisation

Further development of the quality framework for pharmaceutical wholesale distribution.

2026

International cooperation & distribution expansion

The start of a cooperation with an internationally active pharmaceutical company and the addition of TJ-Motion® to our distribution portfolio.

Today

Scalable processes

A continued focus on dependable B2B supply, data quality and long-term partnerships.

What we stand for

Openness Reliability Responsibility Cohesion